Fundamental Data for GSK

GlaxoSmithKline is one of the world''s leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.

# Employees: 99003

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

No Information

Dividend

Ex-Dividend Date: 11/4/2009

Annual Dividend: $1.85

Current Dividend Yield: $4.39

Dividend Paid (3 months): $0.49

Indicated Dividend: $0.52

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/4/2010

Mean EPS (Next Qtr): $1.13

Mean EPS (Year): $3.92

Mean Estimate(Long Term): $4.11

P/E Ratio(Based on EPS estimate): 10.780

Number of Estimates: 10

Shares Performance

Period	GSK	Compare to S&P
YTD	13.39 %	-6.17 %
4 Weeks	2.67 %	-2.53 %
12 Weeks	8.25 %	0.80 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1628385

Shares Outstanding: 2594M

Market Cap: $109.64B

52 Week High: $42.88

52 Week Low: $27.27

P/E Ratio: 12.040

PEG Ratio: 2.620

Split: On 11/12/1991 GSK split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -8.82 %

EPS Growth in Last Year: -1.06 %

Sales Growth in Last Quarter: 5.41 %

Sales Growth in Last Quarter: -0.55 %

Financials

Qtr Book Value: $7.20

Cash Flow/Share: $11.14

Change in Payout Ratio: -0.060

Price/Sales: 2.620